Evidence map›Paper›PMID 22425413›Full record

ArticleBiological psychiatry2012

Vascular risk status as a predictor of later-life depressive symptoms: a cohort study.

Mika Kivimäki, Martin J Shipley, Charlotte L Allan, Claire E Sexton, Markus Jokela, Marianna Virtanen, Henning Tiemeier, Klaus P Ebmeier, Archana Singh-Manoux

Abstract read
In one paragraph

Article in Biological psychiatry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. The Age-Dependent Association Between Vascular Risk Factors and Depressed Mood.The journals of gerontology. Series B, Psychological sciences and social sciences · 2022
    Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Integrating affective and cognitive correlates of heart rate variability: A structural equation modeling approach.International journal of psychophysiology : official journal of the International Organization of Psychophysiology · 2015
    Article
  16. Midlife stroke risk and cognitive decline: a 10-year follow-up of the Whitehall II cohort study.Alzheimer's & dementia : the journal of the Alzheimer's Association · 2013
    Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Mika KivimäkiDepartment of Epidemiology and Public Health, University College London, 1-19 Torrington Place, London, United Kingdom. m.kivimaki@ucl.ac.uk
Martin J Shipley
Charlotte L Allan
Claire E Sexton
Markus Jokela
Marianna Virtanen
Henning Tiemeier
Klaus P Ebmeier
Archana Singh-Manoux

Funding

Socio-economic status and heterogeneity in agingR01AG013196 · NIA · UNIVERSITY OF LONDON INST OF NEUROLOGY · PI MARMOT, MICHAEL G, SINGH-MANOUX, ARCHANA · 1996 to 2013
$3.5M
Socioeconomic gradient in CHD in early old ageR01HL036310 · NHLBI · UNIVERSITY OF LONDON · PI KIVIMAKI, MIKA J, MARMOT, MICHAEL G · 1986 to 2012
$3.1M
Health behaviors over the adult lifecourse and cognitive agingR01AG034454 · NIA · UNIVERSITY COLLEGE LONDON · PI KIVIMAKI, MIKA J, SINGH-MANOUX, ARCHANA · 2009 to 2013
$1.5M
SOCIAL FACTORS INFLUENCING MEDICAL OUTCOME MEASURESR01HS006516 · AHRQ · UNIVERSITY OF LONDON · PI MARMOT, MICHAEL G · 1990 to 1995
–
AHRQ HHS HS06516British Heart Foundation RG/07/008/23674Department of HealthMedical Research Council G0100222Medical Research Council G0902037Medical Research Council G1001354Medical Research Council G19/35Medical Research Council G8802774NHLBI NIH HHS R01 HL036310NHLBI NIH HHS R01HL36310NIA NIH HHS R01 AG013196NIA NIH HHS R01AG013196NIA NIH HHS R01 AG034454NIA NIH HHS R01AG034454
6 · The paper itself

Abstract

backgroundCommon etiology of vascular diseases and later-life depression may provide important synergies for prevention. We examined whether standard clinical risk profiles developed for vascular diseases also predict depressive symptoms in older adults.

methodsData were drawn from the Whitehall II study with baseline examination in 1991; follow-up screenings in 1997, 2003, and 2008; and additional disease ascertainment from hospital data and registry linkage on 5318 participants (mean age 54.8 years, 31% women) without depressive symptoms at baseline. Vascular risk was assessed with the Framingham Cardiovascular, Coronary Heart Disease, and Stroke Risk Scores. New depressive symptoms at each follow-up screening were identified by General Health Questionnaire caseness, a Center for Epidemiologic Studies Depression Scale score ≥16, and use of antidepressant medication.

resultsDiagnosed vascular disease (that is, coronary heart disease or stroke) was associated with an increased risk for depressive symptoms, age- and sex-adjusted odds ratios from 1.5 (95% confidence interval 1.0-2.2) to 2.0 (1.4-3.0), depending on the indicator of depressive symptoms. Among participants without manifest vascular disease, the Stroke Risk Score was associated with Center for Epidemiologic Studies Depression Scale depressive symptoms before age 65 (age- and sex-adjusted odds ratio per 10% absolute change in the score = 3.1 [1.5-6.5]), but none of the risk scores predicted new-onset depressive symptoms in those aged ≥65 (odds ratios from .8 to 1.2).

conclusionsThese data suggest that public health measures to improve vascular risk status will influence the incidence of later-life depressive symptoms via reduced rates of manifest vascular disease.

Indexed as

AdultAgedAged, 80 and overCardiovascular DiseasesCohort StudiesDepressionFemaleHumansLogistic ModelsLongitudinal StudiesMaleMiddle AgedPsychiatric Status Rating ScalesRiskStroke

Identifiers

PMID22425413
PMCPMC3539141

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.